Aua Capital Management, LLC Amgen Inc Transaction History

Aua Capital Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 09, 2022	SELL	$224.46 - $253.15 $107,516 - $121,258	-479 Reduced 43.94%	611 $138,000
Q1 2022 May 04, 2022	BUY	$219.27 - $242.57 $43,854 - $48,514	200 Added 22.47%	1,090 $264,000
Q4 2021 Feb 11, 2022	BUY	$198.88 - $227.6 $37,389 - $42,788	188 Added 26.78%	890 $200,000
Q3 2020 Nov 12, 2020	BUY	$234.65 - $260.95 $73,210 - $81,416	312 Added 80.0%	702 $178,000
Q2 2020 Jul 13, 2020	SELL	$197.81 - $242.74 $59,343 - $72,822	-300 Reduced 43.48%	390 $92,000
Q4 2019 Jan 10, 2020	SELL	$189.21 - $243.2 $53,924 - $69,312	-285 Reduced 29.23%	690 $166,000
Q2 2018 Jul 10, 2018	SELL	$166.05 - $186.51 $8,302 - $9,325	-50 Reduced 4.88%	975 $180,000
Q1 2018 May 15, 2018	BUY	$169.43 - $198.0 $8,471 - $9,900	50 Added 5.13%	1,025 $175,000
Q4 2017 Feb 06, 2018	BUY	$168.79 - $188.59 $8,439 - $9,429	50 Added 5.41%	975 $170,000
Q3 2017 Oct 20, 2017	BUY	$167.29 - $191.0 $154,743 - $176,675	925	925 $172,000

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Aua Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Aua Capital Management, LLC with notifications on news.